|
|
|
Substance Name: Sulfadoxine [USAN:USP:INN:BAN:JAN]
RN: 2447-57-6
UNII: 88463U4SM5
InChIKey: PJSFRIWCGOHTNF-UHFFFAOYSA-N
Note
- A long acting sulfonamide that is used, usually in combination with other drugs, for respiratory, urinary tract, and malarial infections.
Molecular Formula
- C12-H14-N4-O4-S
Molecular Weight
- 310.3326
- All
- Classifications
- Links to Resources
- Names & Synonyms
- Registry Numbers
- Structure Descriptors
- Toxicity
- Physical Properties
Classification Codes
- Anti-Infective Agents
- Anti-Infective Agents, Urinary
- Antibacterial
- Antimalarials
- Antiparasitic Agents
- Antiprotozoal Agents
- Drug / Therapeutic Agent
- Renal Agents
* denotes mobile formatted website
Links to Resources
NLM Resources (File Locators)
Regulatory Agencies (Superlist Locators)
Other Resources (Internet Locators)
Search for this InChIKey on the Web
Names and Synonyms
Name of Substance
- Sulfadoxine
- Sulfadoxine [USAN:USP:INN:BAN:JAN]
MeSH Heading
- Sulfadoxine
Synonyms
- 4-Amino-N-(5,6-dimethoxy-4-pyrimidinyl)benzenesulfonamide
- 4-Sulfanilamido-5,6-dimethoxypyrimidine
- 5-25-13-00306 (Beilstein Handbook Reference)
- 6-(4-Aminobenzenesulfonamido)-4,5-dimethoxypyrimidine
- BRN 0625453
- EINECS 219-504-9
- Fanasil
- Fanzil
- N'-(5,6-Dimethoxy-4-pyrimidyl)sulfanilamide
- N(sup 1)-(5,6-Dimethoxy-4-pyrimidinyl)sulfanilamide
- N1-(5,6-Dimethoxy-4-pyrimidinyl)sulfanilamide
- Ro 4-4393
- Solfadossina
- Solfadossina [DCIT]
- Sulfadoxina
- Sulfadoxina [INN-Spanish]
- Sulfadoxine
- Sulfadoxinum
- Sulfadoxinum [INN-Latin]
- Sulforthomidine
- Sulphadoxine
- Sulphormethoxine
- UNII-88463U4SM5
- WR 4873
Systematic Names
- Benzenesulfonamide, 4-amino-N-(5,6-dimethoxy-4-pyrimidinyl)-
- Sulfadoxine
Mixture Name
- Fansidar
Registry Numbers
CAS Registry Number
- 2447-57-6
FDA UNII
- 88463U4SM5
System Generated Number
- 0002447576
Structure Descriptors
InChI
1S/C12H14N4O4S/c1-19-10-11(14-7-15-12(10)20-2)16-21(17,18)9-5-3-8(13)4-6-9/h3-7H,13H2,1-2H3,(H,14,15,16)InChIKey
PJSFRIWCGOHTNF-UHFFFAOYSA-NSmiles
c1(c(c(ncn1)Toxicity
| Organism | Test Type | Route | Reported Dose (Normalized Dose) | Effect | Source |
|---|---|---|---|---|---|
| dog | LDLo | intravenous | 60mg/kg (60mg/kg) | VASCULAR: BP LOWERING NOT CHARACTERIZED IN AUTONOMIC SECTION | Chemotherapy Vol. 14, Pg. 37, 1969. |
| mouse | LD50 | intraperitoneal | 2900mg/kg (2900mg/kg) | Chemotherapy Vol. 14, Pg. 195, 1969. | |
| mouse | LD50 | oral | 5200mg/kg (5200mg/kg) | Chemotherapy Vol. 14, Pg. 195, 1969. | |
| mouse | LD50 | subcutaneous | 2900mg/kg (2900mg/kg) | Chemotherapy Vol. 14, Pg. 195, 1969. |
Physical Properties
| Physical Property | Value | Units | Temp (deg C) | Source |
|---|---|---|---|---|
| Melting Point | 190-194 | deg C | EXP | |
| log P (octanol-water) | 0.7 | (none) | EXP | |
| Water Solubility | 2700 | mg/L | 25 | EST |
| Vapor Pressure | 1.59E-09 | mm Hg | 25 | EST |
| Henry's Law Constant | 1.42E-15 | atm-m3/mole | 25 | EST |
| Atmospheric OH Rate Constant | 2.83E-11 | cm3/molecule-sec | 25 | EST |
Physical property data is provided to ChemIDplus by SRC, Inc.